Systematic evaluations regarding interparticular mass transfer in spheronization

被引:12
作者
Koester, Martin [1 ]
Willemsen, Emilie [2 ]
Krueger, Cornelia [1 ]
Thommes, Markus [1 ]
机构
[1] Univ Dusseldorf, Inst Pharmaceut & Biopharmaceut, D-40225 Dusseldorf, Germany
[2] Lab Pharmaceut Technol, Ghent, Belgium
关键词
Microcrystalline cellulose; kappa-Carrageenan; Wet extrusion; Spheronization; Mechanism; Mass transfer; ALTERNATIVE PELLETIZATION AID; KAPPA-CARRAGEENAN; MICROCRYSTALLINE CELLULOSE; EXTRUSION/SPHERONISATION; PARAMETERS; PELLETS; FILLER;
D O I
10.1016/j.ijpharm.2012.04.045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pellets are frequently used in pharmaceutical applications. The extrusion-spheronization process is a well-established technique used to produce pellets of a spherical shape and narrow size distribution. In this process, cylindrical extrudates are transformed into spherical pellets by spheronization. Most established mechanisms consider only breakage and deformation to explain pellet formation. An interaction between the rounding extrudates via adhesion of fine particles was not considered for many years. This study deals with the evolution of pellet properties over time during the spheronization process in order to quantify the influence of pellet interactions on their properties. Therefore the most important pelletization aids (MCCI, MCCII and kappa-carrageenan) were investigated using acetaminophen as a model drug and lactose as a filler. In the first seconds of the spheronization process, a high fine fraction was seen which decreased during the process. Simultaneously, the material transferred between the pellets increased. However the fine fraction is not high enough to explain the mass transfer; therefore a direct transfer between the pellets was assumed. The pelletization aid has a huge influence on the amount of mass transferred. Whereas kappa-carrageenan leads to a quite low mass transfer of 15%, MCCI and MCCII show higher values up to 25%. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 18 条
  • [1] STUDY OF PARAMETERS IMPORTANT IN THE SPHERONIZATION PROCESS
    BAERT, L
    VERMEERSCH, H
    REMON, JP
    SMEYERSVERBEKE, J
    MASSART, DL
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 96 (1-3) : 225 - 229
  • [2] CONTROLLED-RELEASE MULTIPLE-UNITS AND SINGLE-UNIT DOSES - LITERATURE-REVIEW
    BECHGAARD, H
    NIELSEN, GH
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1978, 4 (01) : 53 - 67
  • [3] Preliminary assessment of carrageenan as excipient for extrusion/spheronisation
    Bornhöft, M
    Thommes, M
    Kleinebudde, P
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (01) : 127 - 131
  • [4] CONINE JW, 1970, DRUG COSMET IND, V106, P38
  • [5] ERKOBONI DF, 2003, PHARM EXTRUSION TECH, P277
  • [6] Koester M., 2012, AAPS PHARMSCITECH
  • [7] New Insights into the Pelletization Mechanism by Extrusion/Spheronization
    Koester, Martin
    Thommes, Markus
    [J]. AAPS PHARMSCITECH, 2010, 11 (04): : 1549 - 1551
  • [8] Krueger C., POWDER TECH IN PRESS
  • [9] "MCC SANAQ®burst"-A New Type of Cellulose and its Suitability to Prepare Fast Disintegrating Pellets
    Krueger, Cornelia
    Thommes, Markus
    Kleinebudde, Peter
    [J]. JOURNAL OF PHARMACEUTICAL INNOVATION, 2010, 5 (1-2) : 45 - 57
  • [10] Liew V.C., 2007, AAPS PHARMSCITECH, P8